[Study of the efficacy of semax in global cerebral ischemia in vivo].
Iakovleva
E V
EV
Kuzenkov
V S
VS
Fedorov
V N
VN
Skvortsova
V I
VI
Koshelev
V B
VB
Gusev
E I
EI
Ashmarin
I P
IP
D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000818:Animals; D001157:Arterial Occlusive Diseases / Q000150:complications; D002545:Brain Ischemia / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D002340:Carotid Artery Diseases / Q000150:complications; D008297:Male; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010446:Peptide Fragments / Q000627:therapeutic use*; D051381:Rats
D018696:Neuroprotective Agents; D010446:Peptide Fragments; C048487:ACTH (4-7), Pro-Gly-Pro-; D000324:Adrenocorticotropic Hormone